The Effect of Maximal and Submaximal Exercise Testing on NT-proBNP Levels in Patients with Systolic Heart Failure
By: Dumitru Tudor Zdrenghea, Maria Ilea, Mihnea D.T. Zdrenghea, Adela Viviana Sitar-Tǎut and Dana Pop
Open Access
|Mar 2014References
- 1. Thygesen K, Mair J, Mueller C, Huber K, Weber M, Plebani, et al. Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J 2012;33(16):2001-6. DOI: 10.1093/ eurheartj/ehq509
- 2. Sudoh T, Maekawa K, Kojima M, Minamino N, Kangawa K, Matsuo H, et al. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun. 1989;159(3):1427-34. DOI: 10.1016/0006-291X(89)92269-9
- 3. Mair J. Biochemistry of B-type natriuretic peptide? where are we now? Clin Chem Lab Med 2008;46(11):1507-14.
- 4. Clerico A, Emdin M. Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem. 2004;50(1):33-50. DOI: 10.1373/clinchem.2003.024760
- 5. Baicu CF, Zile MR, Aurigemma GP, Gaasch WH. Left ventricular systolic performance, function and contractility in patients with diastolic heart failure. Circulation. 2005;111(18):2306-12. DOI: 10.1161/01. CIR.0000164273.57823.26
- 6. Zdrenghea D, Ilea M, Pop D, Petrovai D, Bodisz G, Zdrenghea M. N-terminal Pro B-type Natriuretic Peptide During Exercise In Patients With Systolic And Diastolic Heart Failure. Acta Endocrinologica (Buc). 2009;5(1):19-25. DOI: 10.4183/aeb.2009.19
- 7. Ilea M, Zdrenghea D, Bodisz G, Malai A, Gheorghiu L, Predescu D, et al. Cardiac peptides during exercise test in ischemic and non-ischemic heart failure patients. Rom J Intern Med. 2008;46(1):63-8.
- 8. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al . The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012;33(14):1787-847. DOI: 10.1093/eurheartj/ehs104
- 9. Zdrenghea D, Beudean M, Pop D, Zdrenghea V. Four hundred meters walking test in the evaluation of heart failure patients. Rom J Intern Med. 2010;48(1):33-8.
- 10. Konstam MA. Natriuretic peptides and cardiovascular events:more than a stretch. JAMA. 2007;297(2):212-4. DOI: 10.1001/jama.297.2.212
- 11. Guglin M, Hourani R, Pitta S. Factors Determin ing Extreme Brain Natriuretic Peptide Elevation. Congestive Heart Failure. 2007;13(3):136-41. DOI: 10.1111/j.1527-5299.2007.06478.x
- 12. Kallistratos MS, Pavlidis AN, Chamodraka ES, Varounis C, Dritsas A, Laoutaris ID, et al. Prognostic value of NT-proBNP at rest and peak exercise in patients with impaired left ventricular function. Angiology. 2012;63(7):516-21. DOI: 10.1177/0003319711429328
- 13. Cipriano G Jr, Cipriano VT, da Silva VZ, Cipriano GF, Chiappa GR, de Lima AC, et al. Aerobic exercise effect on prognostic markers for systolic heart failure patients: a systematic review and meta-analysis. Heart Fail Rev. 2013 Oct 16 [Epub ahead of print]. DOI: 10.1007/s10741-013-9407-6
- 14. Ingle L, Rigby AS, Carroll S, Butterly R, King RF, Cooke CB, et al. Prognostic value of the 6 min walk test and self-perceived symptom severity in older patients with chronic heart failure. Eur Heart J 2007;28(5):560-8. DOI: 10.1093/eurheartj/ehl527
- 15. Hogenius J, Voors AA, Jaarsma T, Hillege HL, Boomsma F, van Veldhuisen DJ. Influence of age on natriuretic peptide in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. Eur J Heart Fail. 2005;7(1):81-6. DOI: 10.1016/j.ejheart. 2004.03.014
- 16. Magne J, Mahjoub H, Pibarot P, Pirlet C, Pierard LA, Lancellotti P. Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation. Eur J Heart Fail. 2012;14(11):1293-302. DOI: 10.1093/eurjhf/hfs114
- 17. Huang WS, Lee MS, Perng HW, Yang SP, Kuo SW, Chang HD. Circulating brain natriuretic peptide values in healthy men before and after exercise. Metabolism. 2002;51(11):1423-6. DOI: 10.1053/meta.2002.35194
- 18. Krupicka J, Janota T, Kasalová Z, Hradec J. Effect of short-term maximal exercise on BNP plasma levels in healthy individuals. Physiol Res. 2010;59(4):625-8.
- 19. Foote RS, Pearlman JD, Siegel AH, Yeo KT. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol. 2004 ;44(10):1980-7. DOI: 10.1016/j.jacc.2004.08.045
- 20. Staub D, Jonas N, Zellweger MJ, Nusbaumer C, Wild D, Pfisterer ME, et al. Use of N-terminal pro-B-type natriuretic peptide to detect myocardial ischemia. Am J Med. 2005;118(11):1287. DOI: 10.1016/j.amjmed. 2005.05.020
- 21. Mak GS, DeMaria A, Clopton P, Maisel AS. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J. 2004;148(5):895-902. DOI: 10.1016/j.ahj.2004.02.016
- 22. Chinnaiyan KM, Alexander D, Maddens M, Mc- Cullough PA. Curriculum in cardiology: integrated diagnosis and management of diastolic heart failure. Am Heart J. 2007;153 (2):189-200. DOI: 10.1016/j. ahj.2006.10.022
- 23. Zdrenghea D, Pop D, Ilea M. Cardiac Peptides During Isometric Exercise in Patients With Diastolic Dysfunction. Current Advances in Heart Disease. 2008;265-8.
- 24. Danzig V, Míková B, Kuchynka P, Benáková H, Zima T, Kittnar O, et al . Levels of circulating biomarkers at rest and after exercise in coronary artery disease patients. Physiol Res. 2010;59(3):385-92.
- 25. Guazzi M, Vitelli A, Arena R. The effect of exercise training on plasma NT-pro-BNP levels and its correlation with improved exercise ventilatory efficiency in patients with heart failure. Int J Cardiol. 2012;158(2):290-1. DOI: 10.1016/j.ijcard.2012.04.091
- 26. Madaric J, Watripont P, Bartunek J, Casselman F, Vanderheyden M, Van Praet F, et al. Effect of mitral valve repair on exercise tolerance in asymptomatic patients with organic mitral regurgitation. Am Heart J. 2007;154(1):180-5. DOI: 10.1016/j.ahj.2007.03.051
- 27. Mak GS, DeMaria A, Clopton P, Maisel AS. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J. 2004;148(5):895-902. DOI: 10.1016/j.ahj.2004.02.016
- 28. Suntharalingam J, Goldsmith K, Toshner M, Doughty N, Sheares KK, Hughes R, et al. Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension. Respir Med. 2007;101(11):2254-62. DOI: 10.1016/j.rmed.2007.06.027
- 29. Frantz RP, McDevitt S, Walker S. Baseline NT-proBNP correlates with change in 6-minute walk distance in patients with pulmonary arterial hypertension in the pivotal inhaled treprostinil study TRIUMPH-1. J Heart Lung Transplant. 2012;31(8):811-6. DOI: 10.1016/j. healun.2012.04.005
DOI: https://doi.org/10.2478/rrlm-2014-0008 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624 (formerly 2284-5623)
Language: English, Romanian
Page range: 25 - 33
Published on: Mar 25, 2014
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Related subjects:
© 2014 Dumitru Tudor Zdrenghea, Maria Ilea, Mihnea D.T. Zdrenghea, Adela Viviana Sitar-Tǎut, Dana Pop, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons License.